AACR Holds Congressional Briefing on Strengthening Prevention of E-Cigarette Use in Youth

US Capitol Building

Policymakers, parents, teachers, and public health professionals have all expressed concern about the rise in teen vaping and a strong desire to find ways to reverse the trend. On Wednesday, the American Association for Cancer Research held a congressional briefing to update policymakers and the public on the latest scientific evidence related to e-cigarettes and to start a dialogue about challenges and potential solutions in prevention of youth vaping.

Read More

FDA Expands Use of Pembrolizumab to Two Additional Cancer Types

Last week, the U.S. Food and Drug Administration (FDA) increased the number of types of cancer for which pembrolizumab (Keytruda) is a treatment option when it approved the immunotherapeutic for treating certain patients with cervical cancer and certain patients with non-Hodgkin lymphoma.

Read More

STAR Act Aims to Boost Pediatric Research

This week, President Trump signed the Childhood Cancer Survivorship, Treatment, Access and Research (STAR) Act, which is aimed at supporting pediatric cancer research. The legislation calls for expanding the collection of patient biospecimens and records, improving surveillance, and investigating pediatric survivorship.

Read More

FDA Approves Targeted Therapy Combo for Thyroid Cancer

On May 4, the U.S. Food and Drug Administration (FDA) approved a combination of molecularly targeted therapeutics for the treatment of a certain type of thyroid cancer. Specifically, the FDA approved the use of dabrafenib (Tafinlar) in combination with trametinib (Mekinist) for treating patients who have anaplastic thyroid cancer that cannot be removed by surgery or that has metastasized, and that tests positive for a BRAF V600E gene mutation.

Read More

Early-career Researchers Share Their Passions on Capitol Hill

US Capitol Building

Each year, the American Association for Cancer Research (AACR) is proud to bring Associate Members to Washington, D.C., where they meet with legislators and policymakers to discuss issues that are critical to supporting medical research.

Read More